SCHEMBL4720115

SCHEMBL4720115

Cc1cc(CC(NC(=O)ON2CCC(N3Cc4ccccc4NC3=O)CC2)C(=O)N2CCC(C3CCN(C)CC3)CC2)cc(Br)c1Cl

nearest known ligand 0.53

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CALCA P06881 1/20 0.53
CALCRL Q16602 18/20 0.52
CYP3A4 P08684 11/20 0.52
RAMP1 O60894 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4717363 0.94 CALCRL (0.56) CALCACALCRLCYP3A4
SCHEMBL4716878 0.94 CALCRL (0.57) CALCACALCRLCYP3A4
SCHEMBL4718734 0.92 CALCRL (0.62) CALCRLCYP3A4
SCHEMBL4721310 0.91 CALCRL (0.52) CALCACALCRLCYP3A4
SCHEMBL3307869 0.91 CALCA (0.63) CALCACALCRLCYP3A4RAMP1
SCHEMBL4720343 0.90 CALCRL (0.52) CALCACALCRLCYP3A4
SCHEMBL6223278 0.89 CALCRL (0.54) CALCACALCRLCYP3A4
SCHEMBL4720521 0.88 CALCRL (0.59) CALCACALCRLCYP3A4RAMP1
SCHEMBL3307013 0.86 CALCRL (0.67) CALCACALCRLCYP3A4
SCHEMBL4717484 0.85 CALCRL (0.56) CALCACALCRLCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1558600-B1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA (DE) 2008-05-07 EP claimed
EP-1558600-B1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA (DE) 2008-05-07 EP disclosed
EP-1558600-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-08-03 EP disclosed
WO-2004037810-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-05-06 WO disclosed